EGFR and non-small cell lung carcinoma: Additionally, miR30b also acted as an apoptosis inhibitor through the targeting of caspase 3 in a glioblastoma model and EGFR in a non-small-cell lung cancer model, leading to apoptosis resistance and drug resistance [33].